Kendall Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $978K | Buy |
8,822
+105
| +1% | +$11.6K | 0.26% | 99 |
|
|
2025
Q1 | $977K | Buy |
8,717
+25
| +0.3% | +$2.8K | 0.29% | 94 |
|
|
2024
Q4 | $803K | Buy |
8,692
+310
| +4% | +$28.6K | 0.23% | 112 |
|
|
2024
Q3 | $703K | Buy |
8,382
+1,065
| +15% | +$89.3K | 0.22% | 124 |
|
|
2024
Q2 | $502K | Buy |
7,317
+3,705
| +103% | +$254K | 0.17% | 141 |
|
|
2024
Q1 | $265K | Buy |
3,612
+25
| +0.7% | +$1.83K | 0.09% | 187 |
|
|
2023
Q4 | $291K | Hold |
3,587
| – | – | 0.11% | 171 |
|
|
2023
Q3 | $269K | Buy |
3,587
+895
| +33% | +$67.1K | 0.12% | 167 |
|
|
2023
Q2 | $207K | Buy |
+2,692
| New | +$207K | 0.09% | 190 |
|
|
2021
Q2 | – | Sell |
-3,125
| Closed | -$202K | – | 153 |
|
|
2021
Q1 | $202K | Sell |
3,125
-425
| -12% | -$27.5K | 0.13% | 139 |
|
|
2020
Q4 | $207K | Sell |
3,550
-175
| -5% | -$10.2K | 0.15% | 122 |
|
|
2020
Q3 | $235K | Sell |
3,725
-175
| -4% | -$11K | 0.2% | 108 |
|
|
2020
Q2 | $300K | Sell |
3,900
-15
| -0.4% | -$1.15K | 0.29% | 93 |
|
|
2020
Q1 | $293K | Hold |
3,915
| – | – | 0.33% | 82 |
|
|
2019
Q4 | $254K | Sell |
3,915
-198
| -5% | -$12.8K | 0.2% | 106 |
|
|
2019
Q3 | $261K | Hold |
4,113
| – | – | 0.23% | 98 |
|
|
2019
Q2 | $278K | Sell |
4,113
-52
| -1% | -$3.52K | 0.25% | 96 |
|
|
2019
Q1 | $271K | Sell |
4,165
-480
| -10% | -$31.2K | 0.26% | 94 |
|
|
2018
Q4 | $291K | Sell |
4,645
-1,701
| -27% | -$107K | 0.3% | 85 |
|
|
2018
Q3 | $490K | Sell |
6,346
-2,144
| -25% | -$166K | 0.42% | 71 |
|
|
2018
Q2 | $601K | Sell |
8,490
-3,127
| -27% | -$221K | 0.53% | 61 |
|
|
2018
Q1 | $876K | Sell |
11,617
-2,075
| -15% | -$156K | 0.76% | 43 |
|
|
2017
Q4 | $981K | Buy |
+13,692
| New | +$981K | 0.87% | 39 |
|